Latest Platform delivers new capabilities to streamline lab workflows and support customers’ data-informed decision making

• Electronic Lab Notebook (ELN) integrated with Microsoft Office for the Web for live editing and compatibility across all devices supporting Microsoft Office for the Web
• Web-based visualization and analytics workspaces extended to include formulations and animal model data, giving researchers a seamless translation of data to insights that can be communicated in real-time
• Enhanced reactions and transformations, metadata handling and structure alignment, for improved reaction planning in Dotmatics ELN
• Assay Data Management functionality provides greater flexibility in calculations and statistics, and improved user experience and speed
• Platform Authentication – new user sign-in experience that provides enhanced security configuration options and increased flexibility for external identity providers and organizational compliance

Michael Swartz, Senior Vice President Enterprise Product at Dotmatics, commented: “Platform 22.1 demonstrates our commitment to advancing scientific innovation through supporting a wider range of capabilities that serve our customers’ ever-evolving needs for new science, new modalities and enhanced interoperability. Our mission is to help customers make decisions from their complex scientific data, faster, and we look forward to continue achieving this through our new platform.”

For more information visit www.dotmatics.com

About Dotmatics Ltd. www.dotmatics.com

Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research – accelerating the journey towards full digitalization and the Lab of the Future.

With a mission to give scientists access to all of their data, all of the time, Dotmatics provides a unique portfolio of tools for fully automated, end-to-end workflows including data acquisition, knowledge management, data storage, enterprise querying and reporting, and data analytics and visualization. Through these comprehensive solutions, the Company is helping its customers to increase lab efficiency and make better informed decisions driven by all data.

Dotmatics’ customers include many of the world’s leading pharmaceutical, biotechnology, contract research, chemicals and materials companies. Insight into the challenges faced by these organizations enables Dotmatics to focus on delivering versatile and intuitive products and services that have potential to turn around the productivity deficit in research and accelerate development of novel drug candidates or products.

Dotmatics was founded in 2005 by two scientists from Merck Pharmaceuticals (MSD). Since then, it has built a strong and profitable business and in 2020 acquired BioBright, a Boston-based company automating secure data collection and analysis from laboratory and biomanufacturing environments. Dotmatics is now an expert team of over 300 scientists, software developers and engineers, and project managers. The Company is headquartered in the UK with offices in USA, Korea and Japan.

In April 2021, Dotmatics was acquired by Insightful Science and combined, are now the world’s largest cloud-based scientific research R&D platform.

About Insightful Science www.insightfulscience.com

Insightful Science is a scientific software company that is enabling the Cloud for Scientific Discovery. From developing new personalized and preventive patient treatment solutions to reversing climate change — more than two million researchers at leading life science, biopharma and chemical and materials enterprises trust Insightful Science products to make the world a healthier, cleaner, and better place to live. Products within the Insightful Science portfolio were built by prominent scientists, and include GraphPad Prism, Geneious Prime and Geneious Biologics, Dotmatics, SnapGene, nQuery, Cytapex, ProteinMetrics, Omiq and more.